+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Facial Injectables Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • August 2021
  • Region: Global
  • TechNavio
  • ID: 5454732
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the facial injectables market and it is poised to grow by $ 2.76 bn during 2021-2025, progressing at a CAGR of 8.91% during the forecast period. This report on the facial injectables market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the shift from invasive to minimally invasive and non-invasive procedures and increase in beauty consciousness among consumers. In addition, the shift from invasive to minimally invasive and non-invasive procedures is anticipated to boost the growth of the market as well.

The facial injectables market analysis includes the product segment and geographic landscape.

The publisher's facial injectables market is segmented as below:


By Product

  • Botox
  • Dermal fillers

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW
This study identifies the growing demand for facial injectables among older population as one of the prime reasons driving the facial injectables market growth during the next few years.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report on facial injectables market covers the following areas:
  • Facial injectables market sizing
  • Facial injectables market forecast
  • Facial injectables market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading facial injectables market vendors that include AbbVie Inc., Bloomage Biotechnology Corp Ltd., Croma Pharma GmbH, Galderma SA, Hangzhou Techderm Biological Products Co. Ltd., Medytox Inc., Merz Pharma GmbH and Co. KGaA, Prollenium Medical Technologies Inc., Sinclair Pharma Group, and Suneva Medical. Also, the facial injectables market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary
  • Market overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Botox - Market size and forecast 2020-2025
  • Dermal fillers - Market size and forecast 2020-2025
  • Market opportunity by Product
Customer landscape
  • Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Bloomage Biotechnology Corp Ltd.
  • Croma Pharma GmbH
  • Galderma SA
  • Hangzhou Techderm Biological Products Co. Ltd.
  • Medytox Inc.
  • Merz Pharma GmbH and Co. KGaA
  • Prollenium Medical Technologies Inc.
  • Sinclair Pharma Group
  • Suneva Medical
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Product - Market share 2020-2025 (%)
22: Comparison by Product
23: Botox - Market size and forecast 2020-2025 ($ million)
24: Botox - Year-over-year growth 2020-2025 (%)
25: Dermal fillers - Market size and forecast 2020-2025 ($ million)
26: Dermal fillers - Year-over-year growth 2020-2025 (%)
27: Market opportunity by Product
28: Customer landscape
29: Market share By Geographical Landscape 2020-2025 (%)
30: Geographic comparison
31: North America - Market size and forecast 2020-2025 ($ million)
32: North America - Year-over-year growth 2020-2025 (%)
33: Europe - Market size and forecast 2020-2025 ($ million)
34: Europe - Year-over-year growth 2020-2025 (%)
35: Asia - Market size and forecast 2020-2025 ($ million)
36: Asia - Year-over-year growth 2020-2025 (%)
37: ROW - Market size and forecast 2020-2025 ($ million)
38: ROW - Year-over-year growth 2020-2025 (%)
39: Key leading countries
40: Market opportunity By Geographical Landscape ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: AbbVie Inc. - Overview
48: AbbVie Inc. - Product and service
49: AbbVie Inc. - Key offerings
50: AbbVie Inc. - Key customers
51: AbbVie Inc. - Segment focus
52: Bloomage Biotechnology Corp Ltd. - Overview
53: Bloomage Biotechnology Corp Ltd. - Business segments
54: Bloomage Biotechnology Corp Ltd. - Key offerings
55: Bloomage Biotechnology Corp Ltd. - Key customers
56: Bloomage Biotechnology Corp Ltd. - Segment focus
57: Croma Pharma GmbH - Overview
58: Croma Pharma GmbH - Business segments
59: Croma Pharma GmbH - Key offerings
60: Croma Pharma GmbH - Key customers
61: Croma Pharma GmbH - Segment focus
62: Galderma SA - Overview
63: Galderma SA - Product and service
64: Galderma SA - Key offerings
65: Galderma SA - Key customers
66: Galderma SA - Segment focus
67: Hangzhou Techderm Biological Products Co. Ltd. - Overview
68: Hangzhou Techderm Biological Products Co. Ltd. - Business segments
69: Hangzhou Techderm Biological Products Co. Ltd. - Key offerings
70: Hangzhou Techderm Biological Products Co. Ltd. - Key customers
71: Hangzhou Techderm Biological Products Co. Ltd. - Segment focus
72: Medytox Inc. - Overview
73: Medytox Inc. - Business segments
74: Medytox Inc. - Key offerings
75: Medytox Inc. - Key customers
76: Medytox Inc. - Segment focus
77: Merz Pharma GmbH and Co. KGaA - Overview
78: Merz Pharma GmbH and Co. KGaA - Product and service
79: Merz Pharma GmbH and Co. KGaA - Key offerings
80: Merz Pharma GmbH and Co. KGaA - Key customers
81: Merz Pharma GmbH and Co. KGaA - Segment focus
82: Prollenium Medical Technologies Inc. - Overview
83: Prollenium Medical Technologies Inc. - Business segments
84: Prollenium Medical Technologies Inc. - Key offerings
85: Prollenium Medical Technologies Inc. - Key customers
86: Prollenium Medical Technologies Inc. - Segment focus
87: Sinclair Pharma Group - Overview
88: Sinclair Pharma Group - Business segments
89: Sinclair Pharma Group - Key offerings
90: Sinclair Pharma Group - Key customers
91: Sinclair Pharma Group - Segment focus
92: Suneva Medical - Overview
93: Suneva Medical - Product and service
94: Suneva Medical - Key offerings
95: Suneva Medical - Key customers
96: Suneva Medical - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations

Executive Summary

The publisher Announces the Publication of its Research Report - Global Facial Injectables Market 2021-2025

The publisher recognizes the following companies as the key players in the global facial injectables market: AbbVie Inc., Bloomage Biotechnology Corp Ltd., Croma Pharma GmbH, Galderma SA, Hangzhou Techderm Biological Products Co. Ltd., Medytox Inc., Merz Pharma GmbH and Co. KGaA, Prollenium Medical Technologies Inc., Sinclair Pharma Group, and Suneva Medical.

Commenting on the report, an analyst from the publisher said: 'The latest trend gaining momentum in the market is growing demand for facial injectables among older population.'

According to the report, one of the major drivers for this market is the shift from invasive to minimally invasive and non-invasive procedures.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Bloomage Biotechnology Corp Ltd.
  • Croma Pharma GmbH
  • Galderma SA
  • Hangzhou Techderm Biological Products Co. Ltd.
  • Medytox Inc.
  • Merz Pharma GmbH and Co. KGaA
  • Prollenium Medical Technologies Inc.
  • Sinclair Pharma Group
  • Suneva Medical